Abstract
Activation of the alternative pathway of complement commences with the formation of an initial fluid-phase C3 convertase. Treatment of C3 with the nucleophilic reagent methylamine has previously been shown to result in the cleavage of an intramolecular thioester bond and to induce C3b-like properties, including the ability to form a fluid-phase C3 convertase. This report examines the hypothesis that spontaneous hydrolysis of the thioester generates a derivative of C3 that is responsible for the formation of the initial C3 convertase of the alternative pathway. The rate of spontaneous decay of C3 hemolytic activity in buffer was found to be between 0.2 and 0.4%/h. In the presence of other alternative pathway proteins, the rate of inactivation was 1%/h. The rate of spontaneous inactivation was greatly accelerated by low concentrations of chaotrophic agents such as KSCN or guanidine. Liberation of a sulfhydryl group, not present in native C3, correlated with loss of hemolytic activity, indicating that exposure to chaotropic agents resulted in thioester hydrolysis. Unlike native C3, C3 bearing a single reactive sulfhydryl group was capable of generating fluid-phase C3 convertase with Factors B, D, and P and was cleaved by Factor I (C3b inactivator) in the presence of Factor H (beta 1H). The fragmentation patterns indicated that the C3a domain was covalently associated with the functionally C3b-like C3. Organomercurial agarose was employed for the rapid removal of sulfhydryl-bearing, hemolytically inactive forms of C3 and C3b from native hemolytically active C3.
MeSH Terms
Complement Activating Enzymes/metabolism
Complement Activation
Complement C3/metabolism
Complement C3-C5 Convertases/metabolism
Complement C3b/biosynthesis
Complement Pathway, Alternative
Hemolysis
Hydrolysis
Indicators and Reagents
Protein Denaturation
Sulfhydryl Compounds/metabolism
Chemicals
Complement C3
Indicators and Reagents
Sulfhydryl Compounds
Complement C3b
Complement Activating Enzymes
Complement C3-C5 Convertases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Pangburn M K
Schreiber R D
Müller-Eberhard H J
References (25)
25 references, click to expand
-
Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.
J Immunol. 1966 Nov;97(5):680-5
PMID: 5926456
-
The reaction mechanism of human C5 in immune hemolysis.
J Exp Med. 1970 Oct 1;132(4):775-93
PMID: 5508377
-
The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
Immunology. 1973 Feb;24(2):259-75
PMID: 4632688
-
Initiation of C3 cleavage in the alternative complement pathway.
J Immunol. 1975 Nov;115(5):1357-61
PMID: 809512
-
Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
J Exp Med. 1975 Sep 1;142(3):760-72
PMID: 1165475
-
Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
J Biol Chem. 1975 Nov 10;250(21):8293-301
PMID: 1238393
-
Third component of human complement: purification from plasma and physicochemical characterization.
Biochemistry. 1976 Oct 5;15(20):4513-21
PMID: 823964
-
Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
J Immunol. 1977 Feb;118(2):525-32
PMID: 839069
-
Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
J Exp Med. 1977 Jul 1;146(1):257-70
PMID: 301546
-
Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Proc Natl Acad Sci U S A. 1978 Aug;75(8):3948-52
PMID: 279011
-
Mechanism of action of factor D of the alternative complement pathway.
J Exp Med. 1978 Dec 1;148(6):1498-509
PMID: 82604
-
Characterization of alkylamine-sensitive site in alpha 2-macroglobulin.
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4313-6
PMID: 92026
-
Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.
Biochemistry. 1980 Sep 16;19(19):4471-8
PMID: 7407085
-
Third component of human complement: structural requirements for its function.
Biochemistry. 1980 Sep 16;19(19):4479-85
PMID: 7407086
-
Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
J Exp Med. 1980 Oct 1;152(4):1102-14
PMID: 6903192
-
Effect of methylamine on the structure and function of the fourth component of human complement, C4.
J Biol Chem. 1980 Nov 10;255(21):10025-8
PMID: 7430113
-
Evidence for presence of an internal thiolester bond in third component of human complement.
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764-8
PMID: 6934510
-
Covalent binding and hemolytic activity of complement proteins.
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7194-8
PMID: 6938964
-
Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
Biochemistry. 1981 Jul 21;20(15):4458-67
PMID: 7284336
-
The covalent-binding reaction of complement component C3.
Biochem J. 1981 Jan 1;193(1):115-27
PMID: 7305916
-
The separation of functionally distinct forms of the third component of human complement (C3).
Biochem J. 1981 Mar 1;193(3):963-70
PMID: 6458280
-
Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b.
Scand J Immunol. 1981;13(5):413-31
PMID: 6171865
-
Tissue sulfhydryl groups.
Arch Biochem Biophys. 1959 May;82(1):70-7
PMID: 13650640
-
Isolation and characterization of two beta1-glycoproteins of human serum.
J Exp Med. 1960 Feb 1;111:201-15
PMID: 13726744
-
Isolation and description of proteins related to the human complement system.
Acta Soc Med Ups. 1961;66:152-70
PMID: 14477150